What is Etiometry?
Founded in 2010 and headquartered in Massachusetts, Etiometry operates at the intersection of medical informatics and critical care. The company provides sophisticated software solutions that empower clinicians to synthesize complex patient data into actionable insights. By facilitating real-time, evidence-based decision-making, Etiometry addresses the high-stakes requirements of intensive care units, where precision and speed are paramount. Its market position is defined by a commitment to improving patient outcomes through advanced analytics, positioning the firm as a critical infrastructure provider for modern hospital systems seeking to optimize treatment protocols and clinical efficiency.
How much funding has Etiometry raised?
Etiometry has raised a total of $9.3M across 2 funding rounds:
Debt
$350K
Series A
$9M
Debt (2020): $350K with participation from PPP
Series A (2021): $9M led by Shamrock Holdings and SKK 9i Ventures
Key Investors in Etiometry
Shamrock Holdings
Shamrock Holdings is a private investment firm established by the Disney family, focusing on long-term value creation and responsible capital management across diverse sectors.
SKK 9i Ventures
An investment entity participating in the strategic financing round to support the scaling of high-growth healthcare technology enterprises.
PPP
Public-Private Partnership
What's next for Etiometry?
With the recent influx of capital, Etiometry is well-positioned to scale its enterprise-level operations and expand its footprint within the global healthcare market. The strategic focus will likely shift toward enhancing its proprietary software architecture and deepening its integration capabilities within existing hospital electronic health record systems. As the demand for automated, data-centric clinical support grows, Etiometry is poised to leverage its current financial stability to accelerate product development cycles and broaden its reach into new clinical specialties. This phase of growth will be critical in transitioning the company from a specialized software provider to a foundational element of the digital intensive care ecosystem, ensuring long-term sustainability and market leadership.
See full Etiometry company page
